baber/WOPTO huggingface dataset:
Patent CA-2594449-A1 (CA)
Title: 1,3-diaryl substituted ureas as modulators of kinase activity
Inventor: DESIMONE ROBERT W
IPC: A61P35/04
Filed: 2006-01-13
Abstract: Certain chemical entities chosen from compounds of Formula 1 and pharmaceutically acceptable salts, solvates, crystal forms, chelates, non-covalent complexes, prodrugs, and mixtures thereof, are provided herein.  Pharmaceutical compositions comprising at least one chemical entity and one or more pharmaceutically acceptable vehicle chosen from carriers, adjuvants, and excipients, are also provided herein. Use in treating patients suffering from certain diseases and disorders responsive to angiogenic kinase modulation, which comprise administering to such patients an amount of at least one chemical entity effective to reduce signs or symptoms of the disease or disorder are disclosed. These diseases include cancer, including breast neoplasia, endometrial cancer, colon cancer, and neck sguamous cell carcinoma.  A method for determining the presence or absence of an angiogenic kinase in a sample comprising contacting the sample with at least one chemical entity under conditions that permit detection of activity of the angiogenic kinase, detecting a level of the activity of the angiogenic kinase, and therefrom
Patent CA-2598453-A1 (CA)
Title: Colourants for keratin fibres comprising certain cationic cellulose ether derivatives
Inventor: SCHMENGER JURGEN
IPC: A61K8/73
Filed: 2006-03-10
Abstract: The present application relates to an agent for colouring keratin fibres based on oxidation dye precursors and/or direct dyes, which is characterized in that it comprises, in a suitable cosmetic carrier, at least one cellulose ether with 4,000 to 10,000 anhydroglucose units, which is substituted by (a) per mole of anhydroglucose unit on average 0.0003 to 0.08 mol of a nonionic or cationic hydrophobic substituent containing an alkyl group or arylalkyl group having 8 to 24 carbon atoms and (b) a cationic substituent of the formula (I), [R1R2R3R4N+] (Az-)1/z (I) where R1, R2 and R3, independently of one another, are a methyl or ethyl group, R4 is a -CH2-CH2 group or a -CH2-CHOH-CH2 group, Az- is an anion and z is 1, 2 or 3.
Patent CA-2598576-A1 (CA)
Inventor: BROUILLARD PATRICK M
IPC: D04C3/00
Filed: 2007-08-16
Abstract: A hair-braiding device to braid a mass of hair into true three-stranded brai ds comprising a casing, motor, coordination wheel, two braiding wheels which turn in opposit e directions never simultaneously, locking gears, and a push-button driven system to allo w for the automatic partitioning of a mass of hair into three strands for automated braiding.
Patent CA-2599882-A1 (CA)
Inventor: PROVERB ROBERT J
IPC: D21H17/44
Filed: 2005-10-27
Abstract: The invention relates to a method for sizing a paper product that involves the steps of (a) providing a paper stock system; (b) forming, in the absence of high shearing forces, an aqueous sizing emulsion comprising an alkenylsuccinic anhydride component; (c) submitting the emulsion formed from step b to a post-dilution step in the presence of a cationic component under conditions, in the absence of high shearing forces, that produce a post-diluted emulsion having improved sizing efficacy; (d) adding the post-diluted emulsion to the paper stock; and (e) forming a paper web.
Patent CA-2601629-A1 (CA)
Title: Anti-hiv drug, polypeptide constituting the same, gene encoding the polypeptide and method of producing the anti-hiv drug
Inventor: OMURA SATOSHI
IPC: A61P31/18
Filed: 2005-11-30
Abstract: It is intended to provide an anti-HIV drug characterized by containing multimeric actinohivin; a polypeptide which is multimeric actinohivin; a gene encoding the same; and a method of producing the anti-HIV drug. The anti-HIV  drug inhibits the synctium formation and has an enhanced effect.
Patent CA-2601761-A1 (CA)
Inventor: HARDY YVAN
IPC: B29C70/38
Filed: 2006-03-02
Abstract: The invention concerns a fiber application machine comprising a system for moving a fiber application head, fiber storing means, and fiber conveying means from said storing means to the application head, and at least one tension limiting system (109), arranged between the fiber storing means and the application head, including at least two mutually parallel cylinders (91, 191), whereon a plurality of fibers are capable of being urged to be partly wound, and driving means (192, 193) for rotating said cylinders, substantially at the same speed, said driving means being automatically controlled by a control unit of the machine, such that the peripheral speeds of the cylinders are higher than the moving speed of the fibers at the application roll.
Patent CA-2602167-A1 (CA)
Inventor: NAKAZAWA YOSHIYUKI
IPC: B05B15/12
Filed: 2006-03-24
Abstract: Water is sprayed from a water nozzle (32, 33) of a water-washing device to wash polluted air in a painting booth (14), and then, a liquid polymer substance (57) having a character to adsorb a VOC is spayed from an adsorbent spraying nozzle (51 - 53) to remove the VOC from the air. Baffle (43 - 47) is provided in a discharge duct to prevent the VOC-contained mixed liquid mist from moving with the air. Namely, by causing the air to hit the baffle, the VOC-contained mist turns into drops. Through the water-washing by the water-washing device, VOC adsorption by the mixed liquid and mixed liquid mist removal by the baffle, the polluted air can be sufficiently purified.
Patent CA-2603594-A1 (CA)
Inventor: CHATLAPALLI RAMARAO
IPC: A61K9/20
Filed: 2006-04-26
Abstract: The present invention provides compositions, desirably pharmaceutical compositions, containing micronized tanaproget. The compositions can also contain microcrystalline cellulose, croscarmellose sodium, anhydrous lactose, and magnesium stearate; or can contain microcrystalline cellulose, croscarmellose sodium, sodium lauryl sulfate, povidone, and magnesium stearate. The compositions are useful in contraception and hormone replacement therapy and in the treatment and/or prevention of uterine myometrial fibroids, benign prostatic hypertrophy, benign and malignant neoplastic disease, dysfunctional bleeding, uterine leiomyomata, endometriosis, polycystic ovary syndrome, and carcinomas and adenocarcinomas of the pituitary, endometrium, kidney, ovary, breast, colon, and prostate and other hormone-dependent tumors, and in the preparation of medicaments useful therefor. Additional uses include stimulation of food intake.
Patent CA-2604793-A1 (CA)
Title: Electronic thermometer with selectable modes
Inventor: BISCH MICHAEL E
IPC: G01K7/42
Filed: 2007-09-28
Abstract: An electronic thermometer is configured for selectable predictive modes based upon the same predictive algorithm. A mode selector is adapted for user selection between several modes of operation of the thermometer. Each mode of operation utilizes the same predictive algorithm for estimating the temperature of the subject before the thermometer reaches full equilibrium. Different modes offer users a selection for striking the appropriate balance between response time and precision, based upon user preferences and needs.
Patent CA-2606845-A1 (CA)
Title: Paired main tee clip
Inventor: BANKSTON JOHN
IPC: E04B1/38
Filed: 2006-04-24
Abstract: A clip for accurately and quickly suspending pairs of spaced parallel grid main tees from superadjacent structural channels. The clip works with a separate drop clip that hooks over and depends from the structural channel.  The paired main tee clip has a central body region configured like a conventional grid tee bulb thereby enabling the paired main tee clip to mate with the drop clip in the same way the drop clip mates with a conventional grid tee bulb thereby achieving a system that is cost-effective in manufacture and installation.
Patent CA-2606997-A1 (CA)
Inventor: STANGE KATRIN
IPC: A61K9/00
Filed: 2006-05-11
Abstract: L'invention concerne un procédé de fabrication d'une solution d'albumine aqueuse à partir d'une solution initiale d'albumine contenant des molécules stabilisatrices capables d'occuper des zones de liaison de l'albumine. Selon ledit procédé d'augmentation de la capacité de liaison d'albumine pour d'autres molécules, au moins une partie des molécules stabilisatrices est séparée et extraite de l'albumine de la solution initiale d'albumine. L'invention vise à mettre en oeuvre un procédé permettant une préparation plus simple, rapide et économique d'une solution initiale d'albumine commune, stabilisée, plus respectueuse de l'albumine, avec extraction d'une grande partie des stabilisateurs et augmentation de la capacité de liaison d'albumine. A cet effet, le procédé selon l'invention consiste à mettre la solution initiale d'albumine en contact avec un adsorbeur solide dont l'affinité à au moins une partie, de préférence l'ensemble des molécules stabilisatrices employées, est supérieure à l'affinité de l'albumine aux molécules stabilisatrices correspondantes, et à séparer la solution d'albumine de l'adsorbeur, ledit procédé étant réalisé à un pH > 3.
Patent CA-2607779-A1 (CA)
Title: Process for disposing waste gas comprising sulfur oxides and apparatus thereof
Inventor: ORITA KEIGO
IPC: B01D53/50
Filed: 2007-10-11
Abstract: A method for enlarging the particle diameters of sulfuric acid mists in waste gas and collecting the sulfuric acid mists in high efficiency is provided. A process for disposing waste gas containing sulfur oxides that introduces the waste gas in dry type electrostatic precipitator to remove dusts and then introduces the waste gas in a wet desulfurization apparatus to carry out desulfurization, wherein outside air with a flow rate at which the waste gas introduced in the wet desulfurization apparatus is the dew point of acid is taken in from an introducing tube to mix the outside air in the waste gas.
Patent CA-2607892-A1 (CA)
Title: Chamber for slowing particles flowing in a pneumatic conveyor conduit
Inventor: BEAUJOT NORBERT
IPC: A01C7/08
Filed: 2007-10-25
Abstract: A chamber apparatus for reducing the speed of particles carried in a pneumatic conveyor conduit includes a chamber with an inlet port in the chamber, the inlet port adapted for attachment to the pneumatic conveyor conduit, and an outlet port in a lower portion of the chamber. A plurality of flexible bristles is secured at ends thereof to a wall of the chamber and extend into the chamber such that particles carried in an air stream entering the inlet port contact the bristles. The chamber is configured such that particles falling inside the chamber move out of the chamber through the outlet port.
Patent CA-2610450-A1 (CA)
Title: Automated position control of a surface array relative to a liquid microjunction surface sampler
Inventor: FORD MICHAEL JAMES
IPC: H01J49/04
Filed: 2006-04-18
Abstract: A system (20) and method utilizes an image analysis approach for controlling the probe-to-surface distance of a liquid junction-based surface sampling system for use with mass spectrometric detection. Such an approach enables a hands-free formation of the liquid micro junction used to sample solution composition from the surface and for re-optimization, as necessary, of the micro junction thickness during a surface scan to achieve a fully automated surface sampling system.
Patent CA-2611566-A1 (CA)
Inventor: KEHLER JAN
IPC: C07D209/30
Filed: 2006-06-14
Abstract: The present invention relates to compounds of formula (IV) and their use.</S DOAB>
Patent CA-2612184-A1 (CA)
Title: System and method for authorizing a person to drive a vehicle
Inventor: PICHETTE FREDERIC
IPC: B60R25/00
Filed: 2006-03-06
Abstract: The present invention provides a system and method for authorizing a user of a tractor-trailer to drive the tractor-trailer out of a plurality of tractors and trailers. The system comprises modules such as tractor modules and trailer modules. Each module comprises a user interface and a transceiver. A tractor module is located in each of the tractors and is uniquely associated with that tractor. The tractor module is also operatively associated with systems of that tractor. A trailer module is located in each of the trailers and is uniquely associated with that trailer. The trailer module is also operatively associated with systems of the trailer. In the system, a unique code is associated with each user and a central station sends this unique code to the modules, so that the modules enable the user to drive the tractor with the trailer.
Patent CA-2618723-A1 (CA)
Title: Bis(thio-hydrazide amide) formulation
Inventor: LUNSMANN WALTER JOSEPH
IPC: A61K31/16
Filed: 2006-08-10
Abstract: Disclosed herein are compositions comprising a compound represented by structural formula (I): Formula (I); 2 g of which is reconstitutable in 10 mL  of a water in less than 10 minutes, and methods for preparing these compositions. Also disclosed are compositions comprising a compound represented by structural formula (I) and a pharmaceutically acceptable excipient, wherein the molar ratio of said compound to said excipient is from 1 :20 to 1 :1, and methods for preparing these compositions.
Patent CA-2621067-A1 (CA)
Inventor: SEPPAELAE ULLA
IPC: G01N33/68
Filed: 2006-09-01
Abstract: The invention relates to method for quantification of the absolute amount of allergen in an allergen sample comprising : a) providing a known amount of one or more allergen calibration standard peptide(s) having a sequence of amino acids which is identical with, and optionally unique for, a sequence to be found in the allergen to be quantified and optionally labelling said allergen calibration standard peptide(s), b) degrading the allergen sample to obtain a mixture of peptides, and optionally labelling said peptides with one or more labelling agent(s), wherein at least the peptides in the degraded allergen sample or the calibration standard peptides are labelled, and if both the peptides in the degraded allergen sample and the allergen calibration standard peptide(s) are labelled, the labelling agent(s) used for labelling the allergen calibration standard peptide(s) are different from the labelling agent(s) used for labelling the peptides of the degraded allergen sample, c) quantifying the absolute amount of allergen by correlating the amount of the allergen calibration standard peptide(s) with the amount of the corresponding peptide(s) of the degraded allergen sample by mass analysis.
Patent CA-2621396-A1 (CA)
Inventor: MAKIMURA MICHITO
IPC: C07B61/00
Filed: 2006-08-29
Abstract: Disclosed is a process for producing an unsaturated aliphatic primary amine which can prevent the by-production of a saturated aliphatic primary amine, can yield a product having no turbidness or no precipitate, and can produce an unsaturated aliphatic primary amine having a low coagulation point with good efficiency. Also disclosed is an unsaturated aliphatic primary amine produced by the process. A process for producing an unsaturated aliphatic primary amine comprising the step of performing the hydrogen reduction of an unsaturated aliphatic nitrile having 16 to 22 carbon atoms with a hydrogenation catalyst in the presence of ammonia, wherein the hydrogen reduction is performed under the conditions where an aromatic carboxylic acid amide is added in an amount of 0.01 to 1.0 part by mass based on 100 parts by mass of the unsaturated aliphatic nitrile and the ratio of the fractional pressure of ammonia to that of hydrogen [(ammonia)/(hydrogen)] is adjusted within the range from 8/2 to 6/4; and an unsaturated aliphatic primary amine produced by the process, which has an amine conversion rate as defined by the formula (1) of 95% or higher, and has an iodine value retention rate as defined by the formula (2) of 95% or higher. [Formula 10] (1) AA Amine conversion rate (%) BB (found amine value of unsaturated aliphatic primary amine) CC (calculated amine value of the amine) [Formula 11] (2) DD Iodine value retention ratio (%) EE (iodine value of unsaturated aliphatic primary amine) ~ (molecular weight of the amine) FF  (iodine value of unsaturated aliphatic nitrile) ~ (molecular weight of the nitrile)
Patent CA-2623245-A1 (CA)
Title: Amino-5- [4- (difluoromethoxy) phenyl] -5-phenylimidazolone compounds as inhibitors of the beta-secretase (bace)
Inventor: ERDEI JAMES JOSEPH
IPC: A61K31/4168
Filed: 2006-09-22
Abstract: The present invention provides a 2-amino-5-[4-(difluoromethoxy)phenyl]-5-3,5-dihydro-phenylimidazol-4-one compound of formula (I) The present invention also provides methods for the use thereof to inhibit ~-secretase (BACE) and treat ~-amyloid deposits and neurofibrillary tangles.
Patent CA-2625270-A1 (CA)
Title: Cooling device for motorcycle engine
Inventor: KUSUDA ATSUSHI
IPC: B62K11/00
Filed: 2008-03-11
Abstract: To enable the close arrangement of cooling fans which are common to each other and rotate in the same direction when the cooling fans are provided right and left. A radiator is disposed forward of an engine horizontally lengthwise and formed such that the center thereof bends to protrude rearward. A pair of cooling fans are provided right and left on the rear surface of the radiator. The left and right cooling fans have the same specifications, rotating in the same direction. A support plate is provided to surround the cooling fans, that is, to close left and right sides of, the upper side of and the rear of the cooling fans and open the lower side thereof. A partition portion is formed to project from the center of a rear wall to partition between the left and right cooling fans. Thus, the adjacent cooling fans can be prevented from interfering with each other and enabled to be arranged close to each other.
Patent CA-2626016-A1 (CA)
Title: Pharmaceutical composition comprising at least one anticancer drug and at least one polymer
Inventor: SINGH AMARJIT
IPC: A61K45/08
Filed: 2006-10-19
Abstract: The present invention relates to novel and improved compositions of anticancer drugs, preferably taxanes, such as paclitaxel and docetaxel, their derivatives or their analogues, methods of manufacturing these compositions and methods of fractionating the particles in particular size range and methods of treating cancer patients with these compositions, which provide reduced chemotherapy-induced side-effects especially reduced chemotherapy-induced- alopecia. The composition is such that there is substantially no free drug in the said composition.
Patent CA-2628252-A1 (CA)
Inventor: VOGEL RICHARD C
IPC: A61M27/00
Filed: 2006-07-25
Abstract: An apparatus includes a pressure housing configured to be coupled to a vacuum source and a diaphragm sealingly coupled to the pressure housing. The diaphragm is configured to move in response to the vacuum source. A magnet is coupled to the diaphragm. A magnetic switch is disposed opposite the magnet and is configured to be actuated by the magnet when the magnet is a predetermined distance from the magnetic switch. The magnetic switch is configured to selectively actuate the vacuum source.
Patent CA-2630049-A1 (CA)
Inventor: WEERASINGHE DEEPTHI K
IPC: A23L27/30
Filed: 2006-11-17
Abstract: The present invention relates generally to improving the taste of natural high-potency non-caloric or low-caloric sweeteners and compositions sweetened therewith. In particular, the present invention relates to compositions that can improve the tastes of natural high-potency non-caloric or low-caloric sweeteners by imparting a more sugar-like taste or characteristic. In particular, the compositions and methods provide a more sugar-like temporal profile, including sweetness onset and sweetness linger, and/or a more sugar-like flavor profile, including osmotic taste.
Patent CA-2630641-A1 (CA)
Title: Surfaces structurees a geometrie de couleurs variable
Inventor: WITZMAN MATTHEW R
IPC: B44F1/08
Filed: 2008-05-06
Abstract: On décrit un dispositif optiquement variable qui comprend un substrat avec un réseau de structures pyramidales formé sur ou dans celui-ci. Les structures sont de préférence formées en imprimant des pyramides avec une encre à couleur optiquement variable et en utilisant un procédé dimpression en creux. En variante, la structure peut être formée en formant par gaufrage une couche dencre avec des pyramides positives de manière à produire un réseau de pyramides gaufrées positive. Chacune des structures forme une pyramide avec au moins trois faces inclinées et dans laquelle une ou plusieurs couleurs sont observées quand la visualisation des pyramides varie comme le substrat tourne dau moins 30 degrés autour dun axe orthogonal au substrat. Pour observer un changement de couleur, on tourne le dispositif autour de la surface normale du substrat, tout en gardant le même angle dincidence par rapport à la source et le même angle de visualisation. Diverses formes de pyramides peuvent être utilisées. Toutefois, les pyramides avec des faces planes sont les plus appropriées.
Patent CA-2632895-A1 (CA)
Inventor: SAVANT GAJENDRA
IPC: H01R13/24
Filed: 2006-07-15
Abstract: A connector ( figures 6 and 17) that can be mated without regard for a particular orientation.
Patent CA-2633027-A1 (CA)
Title: Adhesive pharmaceutical preparation
Inventor: OOKUBO KATSUYUKI
IPC: A61K47/32
Filed: 2006-12-13
Abstract: An adhesive preparation of the invention comprises a support and an adhesive layer laminated on one surface thereof. The adhesive layer is characterized by containing a branched monohydric alcohol having 12 to 28 carbon atoms, a drug which is in a liquid state at or near room temperature (with the proviso that a bisoprolol free base is excluded) and a polyisobutylene adhesive. This can specifically increase the compatibility between the polyisobutylene adhesive and the drug. As a result, the blending amount of the drug can be increased, the bleed of drug from the adhesive layer can be suppressed, and further, a sufficient adhesive property can be obtained in the practical point of view.
Patent CA-2634246-A1 (CA)
Title: Removable sharps device for accessing a portal reservoir
Inventor: MICHELS LESTER D
IPC: A61M31/00
Filed: 2006-12-27
Abstract: A portal access device that is adapted to provide longterm access to a port implanted in a patient comprises, a safety needle insertion device. The safety needle inserter assembly has a base having a proximal portion. An arm, to which a needle or a sharp cannula is connected, may be hingedly connected to the base. The sharp cannula extends from the underside of the proximal end of the arm and passes through the base via a bore in the proximal portion of the base. Locking mechanisms are provided at the base and the distal end of the arm so that when the arm is moved away from the base, and as the distal end of the arm pivots about the uprights, the locking mechanisms at the arm and the base coact to lock the arm in place, to maintain the tip of the needle within the bore in the base.
Patent CA-2637848-A1 (CA)
Inventor: RUMMELHOFF ROBERT
IPC: B28B7/28
Filed: 2007-01-04
Abstract: A two-piece cylindrical telescopic canning sleeve comprising an inner lower member and an upper outer member. The outer member is provided with at least one set of a plurality of engagement devices. The inner lower member is provided with at least one set of a plurality of engagement devices complimentary to the engagement devices provided with the outer member. The telescopic canning sleeve is assembled for use by aligning the engagement devices of the outer member with the engagement devices of the lower member, then sliding the outer member over the inner member until the desired functional height of the canning sleeve is reached after which, the outer member is frictionally engaged with the inner member by twisting the outer sleeve member to the inner member so that the complimentary engagement devices frictionally communicate.